Clinical Trials Logo

Clinical Trial Summary

This is a randomized, double blind, placebo-controlled study of the effects of intranasal oxytocin in youths with obesity, ages 12-18 years old. Subjects will be randomized to receive intranasal oxytocin or placebo (3 sprays per nostril, 4 times per day) for 12 weeks. Study visits include screening to determine eligibility, 2-part main study visits at baseline, week 8, and week 12, and safety check-in visits at weeks 1, and 4; phone calls at weeks 2, 6, and 10, with a safety follow-up visit 6 weeks after the last dose of study drug. Study procedures include appetite, behavioral, metabolic, and endocrine assessments.


Clinical Trial Description

In recent years there has been a dramatic increase in obesity and its complications in both children and adults. Earlier treatment substantially reduces the likelihood of developing complications later in life while concurrently improving quality of life and decreasing mortality. Therefore, it is essential to develop safe and effective therapeutic strategies for weight loss, particularly in adolescents. Oxytocin (OXT), a hypothalamic peptide hormone that regulates energy balance, is a novel neuroendocrine weight-loss therapeutic in adults with obesity because it simultaneously reduces energy intake and increases energy expenditure and is well-tolerated. Data are currently lacking regarding effects of OXT administration in adolescents with obesity. The current study is a 12-week randomized controlled trial (RCT) of OXT vs. placebo in 12-18-year old adolescents with obesity. We hypothesize that OXT administration will decrease weight as a consequence of decreased caloric intake and increased energy expenditure, both partially mediated by reduced hypothalamic inflammation (such inflammation drives weight gain by increasing food intake and reducing energy expenditure). Further, OXT will improve metabolic risk markers, such as visceral and intrahepatic fat, systemic inflammation, and serum lipids. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04551482
Study type Interventional
Source Massachusetts General Hospital
Contact Elizabeth A Lawson, MD, MMSc
Phone 617-726-3870
Email ealawson@partners.org
Status Recruiting
Phase Phase 2
Start date July 28, 2021
Completion date September 2027

See also
  Status Clinical Trial Phase
Completed NCT03358524 - Effects of Vitamin E Supplementation on Free Radicals and Fat Level of Obese Adolescence in Jakarta, Indonesia Phase 4
Recruiting NCT04213014 - Guys/Girls Opt for Activities for Life Trial (GOAL) to Increase Young Adolescents' Physical Activity and Healthy Eating Phase 3
Active, not recruiting NCT06089876 - The Use of Mobile Applications in Obese and Overweight Adolescents for Health Improvement N/A
Recruiting NCT05030636 - Novel Role of Exercise Timing in Obesity N/A
Completed NCT02952170 - Impact of Weight Loss Surgery in Adolescents With NAFLD N/A
Recruiting NCT03963557 - Cognitive Function and Body Mass Index in Children and Adolescents
Completed NCT04044833 - Evaluation of the Effects of Planned Trainings Given to Obese Adolescent Girls on Healthy Lifestyle Behaviors and Menstrual Symptoms
Completed NCT05095883 - Correlation Between Body Weight and Foot Progression Angle in Adolescents
Withdrawn NCT05834062 - Phentermine/Topiramate as Preventive Pharmacotherapy for Obesity Phase 2
Recruiting NCT06152068 - Insulin Resistance, Lipid Profile, CRP, IL-18 and Carotid Intima-Media Thickness (CIMT) Diameter in Obese Adolescents
Enrolling by invitation NCT04094324 - Mental Health in Children and Youth Within Pediatric Care
Not yet recruiting NCT05984043 - Piloting a Biofeedback Intervention for Adolescents With Overweight and a History of Adverse Childhood Experiences N/A
Not yet recruiting NCT02973867 - Myokines Role During Obesity N/A
Active, not recruiting NCT04252677 - Health Literacy and Obesogenic Behaviors N/A
Active, not recruiting NCT04719052 - Mediterranean Enriched Diet for Tackling Youth Obesity N/A
Completed NCT05966870 - Unsweetened Sparkling Water and Changes in Sweetness Perception in Adolescents N/A
Recruiting NCT05393570 - Lifestyle Improvement for Teens With Bariatric Surgery N/A
Not yet recruiting NCT06309121 - Effects of the Postbiotic Blend ABB C3 on Adiposity and Glucose Metabolism in Children and Adolescents N/A
Enrolling by invitation NCT05778266 - Effect of L-citrulline and HIIT on Arterial Stiffness and MAFLD in Adolescents N/A
Completed NCT04780828 - Investigation of the Effects of Different Levels of Obesity on the Respiratory System